Atlas Trials

Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo

Clinical trial NCT07152626 · RECRUITING

Trial details

NCT number
NCT07152626
Sponsor
Centre Hospitalier Universitaire de Nice
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Vitiligo
Start date
2026-03-12
Primary completion
2029-01-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.